The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo-Reference-Cited by-同舟云学术

The phosphodiesterase-4 inhibitor roflumilast impacts Schistosoma mansoni ovipositing in vitro but displays only modest antischistosomal activity in vivo

Published:2020-01 Issue: Volume:208 Page:107793
ISSN:0014-4894
Container-title:Experimental Parasitology
language:en
Short-container-title:Experimental Parasitology

Author:

Botros Sanaa S.,El-Lakkany Naglaa M.,Seif el-Din Sayed H.,William Samia,Sabra Abdel-Nasser,Hammam Olfat A.,de Koning Harry P.

Funder

European Commission

Publisher

Elsevier BV

Subject

Immunology,General Medicine,Parasitology,Infectious Diseases

Reference57 articles.

1. Controlling schistosomiasis with praziquantel: how much longer without a viable alternative? Infect;Bergquist;Infect. Dis. Poverty,2017

2. The genome of the African trypanosome Trypanosoma brucei;Berriman;Science,2005

3. High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast;Bethke;Int. J. Clin. Pharm. Ther.,2011

4. Fragment-based screening in tandem with phenotypic screening provides novel antiparasitic hits;Blaazer;J. Biomol. Screen,2015

5. Targeting a subpocket in Trypanosoma brucei B1 assists structure-based drug discovery for African sleeping sickness;Blaazer;J. Med. Chem.,2018

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of potent and orally efficacious phosphodiesterase inhibitors in sCryptosporidium parvum-infected immunocompromised mice;2023-09-26

2. To Target or Not to Target Schistosoma mansoni Cyclic Nucleotide Phosphodiesterase 4A?;International Journal of Molecular Sciences;2023-04-06

3. Investigation of apoptotic and autophagic effects of chronic roflumilastuseontesticulartissueinratsbyimmunohistochemical and immunofluorescence methods;IRAN J BASIC MED SCI;2023

4. The immunomodulatory effects of roflumilast on tachyzoite-bradyzoite transition in a murine model of Toxoplasma gondii;International Immunopharmacology;2022-12

5. Improving translational power in antischistosomal drug discovery;Advances in Parasitology;2022